Kim Q. Do focuses on Neuroscience, Oxidative stress, Schizophrenia, Glutathione and Internal medicine. As a part of the same scientific family, he mostly works in the field of Neuroscience, focusing on Reactive oxygen species and, on occasion, Extracellular, Oxidative phosphorylation, Inhibitory postsynaptic potential, Intracellular and Superoxide dismutase. The study incorporates disciplines such as Psychosis, Prefrontal cortex, GABAergic and Disease in addition to Schizophrenia.
His study with Glutathione involves better knowledge in Biochemistry. The Internal medicine study combines topics in areas such as Acetylcysteine and Endocrinology. His Endocrinology research integrates issues from NMDA receptor, Long-term potentiation and Synaptic plasticity.
His primary areas of study are Neuroscience, Schizophrenia, Glutathione, Oxidative stress and Internal medicine. In his research on the topic of Neuroscience, Homocysteic acid is strongly related with NMDA receptor. His research in Schizophrenia intersects with topics in Acetylcysteine, White matter, Psychosis and Pathophysiology.
His study in the field of GCLC is also linked to topics like Ascorbic acid. His research integrates issues of Hippocampal formation, Neuroinflammation, Disease, Redox and Web of science in his study of Oxidative stress. His study focuses on the intersection of Internal medicine and fields such as Endocrinology with connections in the field of GCLM.
His primary scientific interests are in Neuroscience, Schizophrenia, Psychosis, Oxidative stress and Internal medicine. His research in Neuroscience focuses on subjects like Schizophrenia, which are connected to Face, Cognitive psychology and Brain development. His Schizophrenia research is multidisciplinary, incorporating elements of Acetylcysteine and Pathophysiology.
The concepts of his Oxidative stress study are interwoven with issues in NMDA receptor, Neuroinflammation, Glutathione and Cell biology. His Glutathione study integrates concerns from other disciplines, such as Biomarker and Pharmacology. His Internal medicine research includes elements of White matter, Fractional anisotropy, Endocrinology and Oncology.
His scientific interests lie mostly in Oxidative stress, Schizophrenia, Neuroscience, Psychosis and Internal medicine. His research integrates issues of Neuroinflammation, Glutathione, Endogeny and Cell biology in his study of Oxidative stress. His Schizophrenia research is multidisciplinary, relying on both Acetylcysteine and Evoked potential.
His biological study spans a wide range of topics, including Glutamate receptor, NMDA receptor and Microglia. Kim Q. Do has researched Psychosis in several fields, including Mismatch negativity, Sensory system, Audiology and Contingent negative variation. His studies deal with areas such as Fractional anisotropy, Endocrinology and Psychopharmacology as well as Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial.
Michael Berk;Michael Berk;David Leon Copolov;David Leon Copolov;Olivia Dean;Olivia Dean;Kristy Lu.
Biological Psychiatry (2008)
Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo.
K. Q. Do;A. H. Trabesinger;M. Kirsten-Krüger;C. J. Lauer.
European Journal of Neuroscience (2000)
Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate
Daniela Piani;Karl Frei;Kim Quang Do;Michel Cuénod.
Neuroscience Letters (1991)
Redox dysregulation, neurodevelopment, and schizophrenia
Kim Q Do;Jan H Cabungcal;Anita Frank;Pascal Steullet.
Current Opinion in Neurobiology (2009)
Mapping the human connectome at multiple scales with diffusion spectrum MRI.
Leila Cammoun;Xavier Gigandet;Djalel Eddine Meskaldji;Jean-Philippe Thiran.
Journal of Neuroscience Methods (2012)
Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients.
Suzie Lavoie;Micah M Murray;Patricia Deppen;Maria G Knyazeva.
Neuropsychopharmacology (2008)
Perineuronal nets protect fast-spiking interneurons against oxidative stress
Jan-Harry Cabungcal;Pascal Steullet;Hirofumi Morishita;Rudolf Kraftsik.
Proceedings of the National Academy of Sciences of the United States of America (2013)
Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence
René Gysin;Rudolf Kraftsik;Julie Sandell;Pierre Bovet.
Proceedings of the National Academy of Sciences of the United States of America (2007)
S-nitrosoglutathione in rat cerebellum: identification and quantification by liquid chromatography-mass spectrometry.
Ina Kluge;Ursula Gutteck-Amsler;Markus Zollinger;Kim Quang Do.
Journal of Neurochemistry (2002)
Schizophrenia and Oxidative Stress: Glutamate Cysteine Ligase Modifier as a Susceptibility Gene
Mirjana Tosic;Jurg Ott;Sandra Barral;Pierre Bovet.
American Journal of Human Genetics (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Lausanne
École Polytechnique Fédérale de Lausanne
École Polytechnique Fédérale de Lausanne
University of Zurich
École Polytechnique Fédérale de Lausanne
University College London
King Abdullah University of Science and Technology
Takeda (Japan)
RMIT University
École Polytechnique Fédérale de Lausanne
Imperial College London
National University of Singapore
Stanford University
University of Porto
University of Utah
Kansas State University
University of California, San Diego
James Cook University
University of Wisconsin–Madison
University of Turku
University of Michigan–Ann Arbor
University of Bremen
Northwestern University
University of California, San Francisco
University of Manchester
University of California, Los Angeles